CYAN AG (CYR.DE) Fundamental Analysis & Valuation

FRA:CYR • DE000A2E4SV8

Current stock price

2.16 EUR
0 (0%)
Last:

This CYR.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CYR.DE Profitability Analysis

1.1 Basic Checks

  • CYR had negative earnings in the past year.
  • In the past year CYR has reported a negative cash flow from operations.
  • In the past 5 years CYR always reported negative net income.
  • CYR had a negative operating cash flow in each of the past 5 years.
CYR.DE Yearly Net Income VS EBIT VS OCF VS FCFCYR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -6.26%, CYR is doing worse than 68.97% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -7.08%, CYR is doing worse than 61.21% of the companies in the same industry.
Industry RankSector Rank
ROA -6.26%
ROE -7.08%
ROIC N/A
ROA(3y)-27.68%
ROA(5y)-21.43%
ROE(3y)-36.79%
ROE(5y)-28.44%
ROIC(3y)N/A
ROIC(5y)N/A
CYR.DE Yearly ROA, ROE, ROICCYR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • Looking at the Gross Margin, with a value of 84.83%, CYR is in the better half of the industry, outperforming 78.45% of the companies in the same industry.
  • CYR's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CYR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
CYR.DE Yearly Profit, Operating, Gross MarginsCYR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CYR.DE Health Analysis

2.1 Basic Checks

  • CYR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CYR has less shares outstanding than it did 1 year ago.
  • CYR has more shares outstanding than it did 5 years ago.
  • CYR has a worse debt/assets ratio than last year.
CYR.DE Yearly Shares OutstandingCYR.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CYR.DE Yearly Total Debt VS Total AssetsCYR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • CYR has an Altman-Z score of 5.32. This indicates that CYR is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CYR (5.32) is better than 76.72% of its industry peers.
  • CYR has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.05, CYR belongs to the top of the industry, outperforming 80.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 5.32
ROIC/WACCN/A
WACC7.14%
CYR.DE Yearly LT Debt VS Equity VS FCFCYR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • CYR has a Current Ratio of 2.24. This indicates that CYR is financially healthy and has no problem in meeting its short term obligations.
  • CYR has a better Current ratio (2.24) than 78.45% of its industry peers.
  • A Quick Ratio of 2.24 indicates that CYR has no problem at all paying its short term obligations.
  • The Quick ratio of CYR (2.24) is better than 79.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24
CYR.DE Yearly Current Assets VS Current LiabilitesCYR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CYR.DE Growth Analysis

3.1 Past

  • CYR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.12%, which is quite impressive.
  • The Revenue has grown by 98.99% in the past year. This is a very strong growth!
  • Measured over the past years, CYR shows a very negative growth in Revenue. The Revenue has been decreasing by -23.31% on average per year.
EPS 1Y (TTM)86.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)98.99%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%36.96%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.44% on average over the next years. This is a very strong growth
  • CYR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.14% yearly.
EPS Next Y76.67%
EPS Next 2Y42.59%
EPS Next 3Y33.89%
EPS Next 5Y35.44%
Revenue Next Year28.88%
Revenue Next 2Y25.88%
Revenue Next 3Y23.58%
Revenue Next 5Y21.14%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CYR.DE Yearly Revenue VS EstimatesCYR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M
CYR.DE Yearly EPS VS EstimatesCYR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. CYR.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CYR. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 427.72, which means the current valuation is very expensive for CYR.
  • Based on the Price/Forward Earnings ratio, CYR is valued a bit more expensive than the industry average as 68.10% of the companies are valued more cheaply.
  • CYR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.42.
Industry RankSector Rank
PE N/A
Fwd PE 427.72
CYR.DE Price Earnings VS Forward Price EarningsCYR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400

4.2 Price Multiples

  • CYR's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CYR is more expensive than 67.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 120.95
CYR.DE Per share dataCYR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CYR's earnings are expected to grow with 33.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.59%
EPS Next 3Y33.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CYR.DE Dividend Analysis

5.1 Amount

  • No dividends for CYR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CYR.DE Fundamentals: All Metrics, Ratios and Statistics

CYAN AG

FRA:CYR (3/20/2026, 7:00:00 PM)

2.16

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-25
Earnings (Next)05-13
Inst Owners1.57%
Inst Owner ChangeN/A
Ins Owners35.76%
Ins Owner ChangeN/A
Market Cap46.83M
Revenue(TTM)8.28M
Net Income(TTM)-1.96M
Analysts83.33
Price Target4.44 (105.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 427.72
P/S 5.65
P/FCF N/A
P/OCF N/A
P/B 1.69
P/tB 21.27
EV/EBITDA 120.95
EPS(TTM)-0.1
EYN/A
EPS(NY)0.01
Fwd EY0.23%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.38
BVpS1.28
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.26%
ROE -7.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.83%
FCFM N/A
ROA(3y)-27.68%
ROA(5y)-21.43%
ROE(3y)-36.79%
ROE(5y)-28.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 3.19
Cap/Depr 1.57%
Cap/Sales 0.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 5.32
F-Score5
WACC7.14%
ROIC/WACCN/A
Cap/Depr(3y)16.18%
Cap/Depr(5y)14.33%
Cap/Sales(3y)12.45%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y76.67%
EPS Next 2Y42.59%
EPS Next 3Y33.89%
EPS Next 5Y35.44%
Revenue 1Y (TTM)98.99%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%36.96%
Revenue Next Year28.88%
Revenue Next 2Y25.88%
Revenue Next 3Y23.58%
Revenue Next 5Y21.14%
EBIT growth 1Y-16.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.1%
EBIT Next 3Y39.05%
EBIT Next 5Y31.73%
FCF growth 1Y83.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.64%
OCF growth 3YN/A
OCF growth 5YN/A

CYAN AG / CYR.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CYAN AG (CYR.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CYR.DE.


What is the valuation status for CYR stock?

ChartMill assigns a valuation rating of 1 / 10 to CYAN AG (CYR.DE). This can be considered as Overvalued.


What is the profitability of CYR stock?

CYAN AG (CYR.DE) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for CYR stock?

The Earnings per Share (EPS) of CYAN AG (CYR.DE) is expected to grow by 76.67% in the next year.